CytexOrtho
  • Home
  • Technology
  • News
  • Contact
  • About
    • Mission and Team
    • FAQ
    • Disclosures
Select Page

Cytex Ortho Approval For Clinical Trials

by CytexOrtho | Nov 5, 2024 | In the News

Follow us!

FDA Approves CytexOrtho Hip Human Clinical Trials – New Implants Aim to Regrow Cartilage to Repair Joints

by CytexOrtho | Oct 29, 2024 | In the News

Highly anticipated cartilage repair implant from CytexOrtho receives greenlight to move forward with human clinical trials. Images of CytexOrtho implants DURHAM, N.C., October 29, 2024 /Issuewire.com/ — CytexOrtho, a pioneer in orthopedic joint preservation,...
“Harnessing the Body’s Powerful Ability to Heal”

“Harnessing the Body’s Powerful Ability to Heal”

by CytexOrtho | Jul 29, 2024 | In the News

This Bonezone article by Dan Cook sheds light on three prominent developers in the regenerative medicine field: CytexOrtho, SurGenTec, and Anika Therapeutics. The piece provides an in-depth review of these trailblazing companies’ history and recent advancements....
“CytexOrtho shares the ‘secret sauce’ for its absorbable hip implants”

“CytexOrtho shares the ‘secret sauce’ for its absorbable hip implants”

by CytexOrtho | Jul 29, 2024 | In the News

CytexOrtho has been featured in a Medical Design and Outsourcing article following their victory at the AAOS OrthoPitch competition. The article, written by Jim Hammerand, highlights CytexOrtho’s innovative ReNew implant, which is developed using a unique 3D weaving...
Newsletter June 2024

Newsletter June 2024

by CytexOrtho | Jul 3, 2024 | Newsletters

Listen Here
« Older Entries

Recent Posts

  • Cytex Ortho Approval For Clinical Trials
  • FDA Approves CytexOrtho Hip Human Clinical Trials – New Implants Aim to Regrow Cartilage to Repair Joints
  • “Harnessing the Body’s Powerful Ability to Heal”
  • “CytexOrtho shares the ‘secret sauce’ for its absorbable hip implants”
  • Newsletter June 2024

Recent Comments

  1. Steve Scheftic on Breakthrough Device Designation from the FDA
  • Follow
  • Follow
  • Follow
  • Follow

Products are in development. This is potential future technology and not approved by the FDA and not commercially available. The innovations described above are all currently in development. Features and performances of future technologies may vary. Access to future technologies are contingent upon regulatory approval. Approval timelines are subject to the regulatory process of individual countries and regions and not guaranteed.

© 2025 Cytex Therapeutics, Inc now DBA CytexOrtho. All rights reserved